Thierry André
Impact in
- Oncology top 0.01%
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Cancer Treatment and Pharmacology
- Hepatology top 0.1%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 472
- Colorectal Cancer Treatments and Studies 384
- Cancer Treatment and Pharmacology 101
- Colorectal Cancer Surgical Treatments 69
- Cancer Immunotherapy and Biomarkers 57
-
- Genetic factors in colorectal cancer 170
- Co-authors
- Aimery de Gramont (155 shared papers)Christophe Louvet (130 shared papers)Josep Tabernero (54 shared papers)Christophe Tournigand (86 shared papers)Tamas Hickish (18 shared papers)C. Boni (12 shared papers)C. Topham (7 shared papers)Matilde Navarro (6 shared papers)
- Journals
- Journal of Clinical Oncology (216 papers)Annals of Oncology (96 papers)European Journal of Cancer (31 papers)Clinical Colorectal Cancer (13 papers)Digestive and Liver Disease (9 papers)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
Thierry André
602 papers receiving 32.1k citations
Thierry André's Hit Papers
Peers
Comparison fields: 5 of 179
- Oncology 22.0k
- Hepatology 2.8k
- Pathology and Forensic Medicine 5.6k
- Cancer Research 3.4k
- Pulmonary and Respiratory Medicine 5.8k
Countries citing papers authored by Thierry André
This map shows the geographic impact of Thierry André's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry André with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry André more than expected).
Fields of papers citing papers by Thierry André
This network shows the impact of papers produced by Thierry André. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry André. The network helps show where Thierry André may publish in the future.
Co-authors
The 25 scholars most cited alongside Thierry André, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 647 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer Hit paper breakdown → | 2004 | 2719 |
| 2 | FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study Hit paper breakdown → | 2003 | 2298 |
| 3 | Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study Hit paper breakdown → | 2017 | 2014 |
| 4 | Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial Hit paper breakdown → | 2009 | 1615 |
| 5 | Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer Hit paper breakdown → | 2018 | 1455 |
| 6 | KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab Hit paper breakdown → | 2008 | 1145 |
| 7 | Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial Hit paper breakdown → | 2012 | 843 |
| 8 | Gemcitabine in Combination With Oxaliplatin Compared With Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of a GERCOR and GISCAD Phase III Trial Hit paper breakdown → | 2005 | 760 |
| 9 | Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer Hit paper breakdown → | 2010 | 756 |
| 10 | Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib Hit paper breakdown → | 2016 | 706 |
| 11 | OPTIMOX1: A Randomized Study of FOLFOX4 or FOLFOX7 With Oxaliplatin in a Stop-and-Go Fashion in Advanced Colorectal Cancer—A GERCOR Study Hit paper breakdown → | 2006 | 586 |
| 12 | Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study Hit paper breakdown → | 2022 | 533 |
| 13 | Disease-Free Survival Versus Overall Survival As a Primary End Point for Adjuvant Colon Cancer Studies: Individual Patient Data From 20,898 Patients on 18 Randomized Trials Hit paper breakdown → | 2005 | 523 |
| 14 | 2009 | 486 | |
| 15 | 2007 | 375 | |
| 16 | 2012 | 356 | |
| 17 | 2006 | 345 | |
| 18 | 1997 | 310 | |
| 19 | 2004 | 309 | |
| 20 | 2009 | 300 |
About Thierry André
Thierry André is a scholar working on Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 647 papers that have together received 32.8k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (384 papers), Genetic factors in colorectal cancer (170 papers), Gastric Cancer Management and Outcomes (109 papers), Cancer Treatment and Pharmacology (101 papers), Cancer Genomics and Diagnostics (69 papers), Colorectal Cancer Surgical Treatments (69 papers), Cancer Immunotherapy and Biomarkers (57 papers) and Lung Cancer Treatments and Mutations (54 papers). The work is most often cited by research in Oncology (22.0k citations), Hepatology (2.8k citations), Pathology and Forensic Medicine (5.6k citations), Cancer Research (3.4k citations) and Pulmonary and Respiratory Medicine (5.8k citations). Thierry André has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Aimery de Gramont, Christophe Louvet, Josep Tabernero, Christophe Tournigand, Tamas Hickish, C. Boni, C. Topham, Matilde Navarro, Gérard Lledo and John Bridgewater. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Clinical Colorectal Cancer and Digestive and Liver Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.